A total of 30 cases having bright echogenic liver on ultrasonography and raised ALT levels without Hepatitis B and Hepatitis C infection and without having history of alcohol consumption were referred to Gastroenterology department of BIRDEM Hospital and selected for liver biopsy in the study. The patient's BMI and demographic profiles were recorded and necessary biochemical tests were carried out. After obtaining the histopathological reports, the correlation between different possible risk factors including biochemical findings and histological findings was sorted out. Based on BMI of Asian population, 73.4% of patients were over weight, 23.3% were obese and only 3.3% were with normal BMI. 90% patients presented with diabetes and 80% had some form of dyslipidaemia. 41% patients exhibited hypertriglycerdaemia, 21% had hypercholesterolaemia and both cholesterol and triglyceride were high in 34% patients. Histopathological study revealed that all 30 patients exhibited fatty change with macrovesicular type being the predominant. 43. 
Introduction
NAFLD could possibly be a part of a metabolic syndrome associated with insulin resistance, diabetes, obesity and hypertension. Patients typically present with asymptomatic serum aminotransferase elevation of 2-3 times the normal (1).
Liver Biopsy is useful and effective as a prognostic indicator, but it is an invasive and costly tool to diagnose fatty liver (2) . Hyperechogenic (bright) liver indicates steatosis by ultrasonography (3) .
The prevalence of overweight and obesity is increasing in Bangladesh especially in females due to a change in dietary habits and a sedentary life style. In clinical practice, we frequently encounter bright echogenic liver on ultrasonography in Bangladesh. Many of those patients have elevated liver enzymes especially ALT.
Probably the ultimate diagnosis of those patients is NASH if we exclude alcohol consumption and HBV, HCV infections. But no study has yet been conducted in Bangladesh to determine the ultimate histological diagnosis of those patients. Moreover correlation between demographic and biochemical aspect and histopathologic aspect of the disease has not been studied. Liver biopsy, which is an invasive and expensive procedure and which many patients want to avoid is needed to have histopathological confirmation of NAFLD. Therefore, our aim of study is to determine the histological diagnosis of the patients presenting with bright echogenic liver and elevated liver enzymes and to find the correlation among the different aspects of the disease. The patients presenting with bright echogenic liver on ultrasonography and raised ALT were included in the study. But the patients with hepatitis B and hepatitis C infection, history of alcohol consumption, having history of using steatogenic medications and with serious comorbid disease like significant cardiac, respiratory and renal disease were excluded from the study.
Patients fulfilling the inclusion and exclusion criteria were referred to Gastroenterology department of BIRDEM and selected for liver biopsy in the study. For collection of data a predesigned data collection form was used. Demographic variables like age, sex, height, weight, BMI were recorded. Among the biochemical variables, fasting and 2 hrs after breakfast blood sugar, ALT, AST, Alkaline phosphatase, Sr. bilirubin, Sr. cholesterol, Sr. triglyceride test were carried out. Platelet count and Prothrombin time were measured to assess the fitness for liver biopsy. After obtaining the histopathological report, the correlation between different possible risk factors including biochemical findings and histopathological findings was sorted out.
BMI was calculated by the Quetlet index, i.e., weight in kg /(height in m 2 ). Obesity, overweight and lean status were defined by a BMI of more than 27.5 kg/m2, 23-27.4 kg/m2 and less than 23 kg/m2, respectively, for Asians (4). Fatty liver was diagnosed by ultrasonography using an ATL HDI 5000 abdominal probe. Longtiudinal, subcostal, ascending, and oblique scans were performed. Liver biopsy was performed in all patients using True-cut biopsy needle under local anaesthesia. Histology sections were stained with Hematoxylline-Eosin stain. All biopsies were carefully staged and graded by an experienced pathologist. The histologic grade ( a score of 0-3, derived from the degree of steatosis, hepatocyte ballooning, lobular and portal inflammation ) and the stage of fibrosis (0-4) were scored using the classification as described by modified Brunt et al (5) .
The study protocol was approved by the Medical Ethics Committee of BIRDEM Academy. Informed consent was obtained from the patients informing the explanations of all procedures, consequence of the study and complication of liver biopsy.
Data were analysed using SPSS (Statistical Package for Social Sciences) version 11.5. For each analytical test the level of significance was set at 0.05 and p < 0.05 was considered significant.
Result
A total of 30 cases, ultrasonographically diagnosed as bright echogenic liver with elevated liver enzymes and having no history of alcohol consumption, were enrolled in the study to find their histopathlogical diagnosis, grading of steatosis and staging of fibrosis. The study was also aimed at assessing the association between possible risk factors and histologic findings.
Age distribution of patients
Age distribution of the patients shows that 43.3% were in between 30-40 years of age followed by 20% between 50-60 years, 18.3% between 40-50 years, 6.7% 60 or above 60 years and only 1(3.3%) < 30 years of age. The mean age was 42.4 ± 8.9 years. (Table I) . 
BMI:
Based on BMI of Asian population, the obesity status of the patients was defined. Nearly three-quarter (73.4%) of the patients were over-weight, 23.3% obese and only 1(3.3%) was with normal BMI. The mean BMI was 26.02 ± 2.46 kg/m 2 . (Table II) . 
Presence of risk factors:
Out 30 cases 27(90%) patients presented with diabetes and 24(80%) had some form of dyslipidemia (serum cholesterol > 200 mg/dl and triglyceride > 150 mg/dl)) as revealed on investigation of lipid profile (Fig.2) . 
Steatosis and associated inflammation:
Histological study revealed that 43.3% patients had mild (< 33%) steatosis and the rest 56.7 % had moderate (33 -66%) steatosis. All the 30 patients exhibited fatty change with macrovesicular type being the predominant. Mild degree of lobular and portal inflammation was found in 86.7% and 80% of the cases respectively, while moderate degree of the same inflammations was found in 10% and 16.7% respectively. Only 1(3.3%) case was free from either inflammation (Table III) . (Table V) . Data were analysed using Chi-square (x 2 ) Test; level of significance was 0.05.
Discussion
NAFLD is now recognized as the most common liver disease in the west (6) . It is probably the third common reason for referral to specialist in Gastroenterology and Hepatology (7, 8) . At the same time, Diabetes mellitus and obesity, two closely associated diseases, have been shown to be rapidly increasing in prevalence (9) . In outpatient clinics of Bangladesh, we encounter many patients having bright echogenic liver on ultrasonography and elevated liver enzymes, specially who are diabetic and dyslipidaemic. If hepatitis B and hepatitis C infection and history of alcohol consumption are excluded, these patients are presumed to have NAFLD. As other forms of chronic liver disease specially Autoimmune hepatitis and Heamochromatosis are rare in our country and socioeconomic status of the population is low, we did not go for investigations to exclude these diseases.
As histopathological examination reveals the confirmed diagnosis of NAFLD, we performed liver biopsy of all our patients. All of our patients had steatohepatitis; 53% having moderate and 46.7% having mild steatohepatitis. This is a remarkable finding and is probably due to precise patient selection in our study, exclusion of cases with normal transaminase levels or positive markers of viral hepatitis. Moreover, most of our patients were diabetic (90%), dyslipidaemic (80%), overweight (73.4%) and obese (23.3%), which are established risk factors for NAFLD. As NAFLD is ultimately a histological diagnosis, a wider study in a random population in the community could tell us whether a combination of LFTs and ultrasound of liver examination will allow us to detect patients with NASH without having to perform a liver biopsy.
Consistent with the published literatures, we found that almost all of our patients (96.7%) were either overweight (73.4%) or, obese (23.3%) with a mean BMI of 26.02.
Insulin resistance has been noted to be crucial in the pathogenesis of NAFLD and obesity has been reported to play a major role in insulin resistance (10) (11) (12) . So naturally majority of our patients had frank diabetes mellitus (90%). We observed some form of dyslipidaemia in 80% of our patients. Others have reported similar prevalences (13, 14) . These biochemical and metabolic derangements point to the fact that NAFLD is primarily a metabolic disorder and is widely considered as a component of the metabolic syndrome which carries with it an increased risk of cardiovascular and cerebrovascular diseases (15) .
Liver enzyme levels in our patients were similar to previous reports (16) . The mean ALT level was 105.57 and mean AST level was 55.53. The AST/ALT ratio was below 1 in all patients and mean AST/ALT ratio was 0.53 which is a characteristic and important finding in NAFLD (17) .
Histological examination of the study population showed a broad spectrum of abnormalities that have been reported with NAFLD. Factors affecting the pathogenesis of NAFLD are steatosis, inflammation and fibrosis (18) (19) (20) . 43.3% of our patients has mild steatosis while 56.7% had moderate steatosis which are similar to other reports. 96.7% o of the patients had ballooning degeneration, lobular inflammation and portal inflammation. NAFLD can cause fibrosis and progress to cirrhosis. Alarmingly, 90% of the study population had mild (83.3%) to moderate (6.7%) fibrosis on histology even though they were clinically asymptomatic..
We attempted to find the correlation of liver enzymes and possible risk factors like BMI, Diabetes mellitus and dyslipidaemia with the histological findings. The findings on liver biopsy were not correlated to liver enzymes and other risk factors. Thus the liver enzymes and risk factors do not seem to be good estimates of the severity of liver disease. However, further largescale prospective study is required to find more precise correlation among different aspects of NAFLD. While our patients do not necessarily represent the whole population of NAFLD, we feel that our study provides an important insight into the spectrum of the disease encountered clinically, bearing in mind the feasibility and difficulty in persuading otherwise asymptomatic patients to undergo liver biopsy. Our findings further emphasize the importance of NAFLD and the need to diagnose it before it causes irreversible liver damage.
